Eric Ostertag serves as Executive at Poseida Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Eric Ostertag has executed 58 insider transactions totaling $8.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2021 involved selling 29,702 shares valued at $346.3K.
Eric Ostertag currently holds 827,320 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Ostertag has been a net seller of PSTX stock. They have purchased $500.0K and sold $8.0M worth of shares.
Eric Ostertag's most recent insider trade was on Mar 1, 2021, when they sold 29,702 shares at $11.66 per share.
Get notified when new Form 4 filings are submitted
| $1.17 |
| Discretionary |
| Feb 16, 2021 | PSTX | $1.3M | Sale | 133,149 | $10.00 | Discretionary |
| Feb 10, 2021 | PSTX | $123.9K | Sale | 12,389 | $10.00 | Discretionary |
| Feb 10, 2021 | PSTX | $87.1K | Option Exercise | 67,534 | $1.29 | Discretionary |
| Jan 21, 2021 | PSTX | $44.6K | Sale | 4,462 | $10.00 | Discretionary |
| Jul 14, 2020 | PSTX | $0 | Conversion | 255,845 | $N/A | Discretionary |
| Jul 14, 2020 | PSTX | $0 | Conversion | 350,696 | $N/A | Discretionary |